Cushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects

Bolstered by increasing biotech investments and accelerating healthcare research, the biomedical sciences (BMS) industry has experienced strong growth in recent years, further reinforcing Singapore’s position as a leading biomedical science hub at the heart of Asia.

This report provides an overview of Singapore’s BMS industry and its real estate requirements with the focus on key drivers for the industry, demand, future supply and rentals of life science properties.